Sabra Healthcare REIT Inc (NASDAQ: SBRA) is 21.72% higher on its value in year-to-date trading and has touched a low of $12.83 and a high of $20.03 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SBRA stock was last observed hovering at around $17.50 in the last trading session, with the day’s loss setting it -0.13%.
Currently trading at $17.37, the stock is -4.57% and -6.08% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.31 million and changing -0.74% at the moment leaves the stock 6.98% off its SMA200. SBRA registered 20.96% gain for a year compared to 6-month gain of 21.38%. The firm has a 50-day simple moving average (SMA 50) of $18.506 and a 200-day simple moving average (SMA200) of $16.2195.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -4.77% loss in the last 1 month and extending the period to 3 months gives it a -8.24%, and is -2.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.11% over the week and 2.10% over the month.
Sabra Healthcare REIT Inc (SBRA) has around 48 employees, a market worth around $4.14B and $692.54M in sales. Current P/E ratio is 41.93 and Fwd P/E is 24.74. Profit margin for the company is 14.03%. Distance from 52-week low is 35.39% and -13.28% from its 52-week high. The company has generated returns on investments over the last 12 months (1.85%).
with sales reaching $175.42M over the same period.The EPS is expected to grow by 753.33% this year, but quarterly earnings will post 5.82% year-over-year. Quarterly sales are estimated to grow 7.36% in year-over-year returns.
Sabra Healthcare REIT Inc (SBRA) Top Institutional Holders
531.0 institutions hold shares in Sabra Healthcare REIT Inc (SBRA), with institutional investors hold 100.50% of the company’s shares. The shares outstanding are 236.59M, and float is at 232.73M with Short Float at 7.95%. Institutions hold 99.32% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 34.44 million shares valued at $530.39 million. The investor’s holdings represent 14.8801% of the SBRA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 34.39 million shares valued at $529.56 million to account for 14.8569 of the shares outstanding. The other top investors are PRINCIPAL FINANCIAL GROUP INC which holds 21.41 million shares representing 9.2487% and valued at over $329.66 million, while STATE STREET CORP holds 5.1042 of the shares totaling 11.81 million with a market value of $181.93 million.
Sabra Healthcare REIT Inc (SBRA) Insider Activity
The most recent transaction is an insider purchase by Cusack Catherine, the company’s Director. SEC filings show that Cusack Catherine bought 7,000 shares of the company’s common stock on May 22 ’24 at a price of $14.43 per share for a total of $0.1 million. Following the purchase, the insider now owns 46385.0 shares.
Sabra Healthcare REIT Inc disclosed in a document filed with the SEC on May 14 ’24 that FOSTER MICHAEL J (Director) sold a total of 10,000 shares of the company’s common stock. The trade occurred on May 14 ’24 and was made at $14.68 per share for $0.15 million. Following the transaction, the insider now directly holds 63923.0 shares of the SBRA stock.
